Scorpius Biomanufacturing is a contract development and manufacturing organization (CDMO) that specializes in the biomanufacturing of biologics, offering comprehensive services from discovery through to limited-scale commercial production. The company operates state-of-the-art facilities in San Antonio, Texas, and Manhattan, Kansas, equipped with cleanrooms dedicated to mammalian cell culture and microbial fermentation. Scorpius employs advanced technologies such as miniaturized bioreactors for mammalian cell culture and expandable single-use stirred bioreactor systems for microbial fermentation, optimizing both upstream and downstream processes. Their capabilities also include cGMP-compliant manufacturing, which ensures that products meet stringent regulatory standards throughout the development process.

In addition to manufacturing, Scorpius provides integrated analytical services that support the characterization and quality control of biologics. Their analytical laboratories utilize a variety of sophisticated technologies, including ELISA, HPLC, and flow cytometry, to conduct a range of tests such as stability studies, pharmacokinetics, and immune profiling. The company emphasizes a phase-appropriate approach to analytical method development, ensuring that testing methodologies align with the specific stages of product development. This comprehensive suite of services positions Scorpius as a valuable partner for pharmaceutical and biotech companies looking to advance their biologic programs efficiently and effectively.

United States

Scorpius BioManufacturing is a CDMO with integrated solutions for large molecule cGMP manufacturing, process and analytical method development, product characterization, and release testing needs. Scorpius' facility in San Antonio, TX has capacity for both mammalian and microbial clinical manufacturing projects.

Scorpius Biomanufacturing

Company Details